Masimo Corp

General ticker "MASI" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $7.6B (TTM average)

Masimo Corp follows the US Stock Market performance with the rate: 60.1%.

Estimated limits based on current volatility of 3.1%: low 148.54$, high 158.80$

Factors to consider:

  • US accounted for 53.8% of revenue in the fiscal year ended 2024-12-28
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-28 to 2026-12-28

  • 2024-12-28 to 2025-12-28 estimated range: [125.63$, 198.37$]
  • 2025-12-28 to 2026-12-28 estimated range: [106.89$, 177.82$]

Financial Metrics affecting the MASI estimates:

  • Negative: negative Net income
  • Negative: negative Operating income
  • Positive: Non-GAAP EPS, $ of 4.41 > 2.19
  • Positive: 22.52 < Shareholder equity ratio, % of 40.06 <= 43.26
  • Negative: Industry operating cash flow per share per price (median), % of -5.43 <= 2.82
  • Negative: negative Industry operating income (median)
  • Negative: Investing cash flow per share, $ of -0.96 <= -0.87
  • Positive: Interest expense per share, $ of 0 <= 0
  • Negative: Industry earnings per price (median), % of -6.18 <= 0
  • Negative: Operating cash flow per share per price, % of 2.14 <= 7.09

Similar symbols

Short-term MASI quotes

2025-03-062025-03-072025-03-102025-03-112025-03-122025-03-132025-03-142025-03-172025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-16140150160170180
Price $

Long-term MASI plot with estimates

100150200250Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 202600.511.5
MASIS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-30 2024-12-28
Operating Revenue $2,035.80MM $2,030.30MM $2,093.90MM
Operating Expenses $1,825.80MM $1,893.80MM $2,360.60MM
Operating Income $210.00MM $136.50MM $-266.70MM
Non-Operating Income $-16.60MM $-48.40MM $-38.60MM
R&D Expense $191.40MM $175.20MM $222.80MM
Income(Loss) $193.40MM $88.10MM $-305.30MM
Taxes $49.90MM $6.60MM $-0.40MM
Profit(Loss)* $143.50MM $81.50MM $-304.90MM
Stockholders Equity $1,338.90MM $1,364.80MM $1,051.90MM
Inventory $501.00MM $545.00MM $459.20MM
Assets $3,210.60MM $3,041.50MM $2,625.70MM
Operating Cash Flow $29.40MM $94.10MM $196.40MM
Capital expenditure $56.30MM $44.00MM $20.00MM
Investing Cash Flow $-1,057.70MM $-81.20MM $-51.20MM
Financing Cash Flow $520.40MM $-57.10MM $-125.60MM
Earnings Per Share** $2.68 $1.54 $-5.72

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.